Safety of MT-401-OTS in Patients With Relapsed AML or MDS

NCT06552416 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Marker Therapeutics, Inc.

Collaborators